Aarti Drugs Stock (NSE:AARTIDRUGS)


INR 515.50
Today's Range
INR508.80 - INR525.00
52-Week Range
INR419.00 - INR840.19
Market Cap

About Aarti Drugs (NSE:AARTIDRUGS)

(NSE:AARTIDRUGS) Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. It offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment. The company also provides pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, raloxifene, and zolpidem; and specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, cipro Q acid, levofloxacin Q acid, methyl nicotinate, N-methyl methane sulphonamide, diphenyl sulphone, norofloxacin Q acid, ofloxacin Q acid, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, para toluene sulphonyl chloride, and sodium benezene sulfinate. In addition, its products under development comprise Acamprosate for alcoholism; Dabigatran for use as an anticoagulant; Sevelamer for antihyperphosphatemia; Colsevelam for anti-cholestrol treatment; Drondarone and Olmesartan for the treatment of cardiovascular diseases; Valasartan for use as cardiprotectant; and Sitagliptin for use as an antidiabetic. Additionally, the company offers contract manufacturing services. Aarti Drugs Limited was founded in 1984 and is headquartered in Mumbai, India.
Show more


Statistics Highlights (NSE:AARTIDRUGS)

Shares Outstanding 92.60M Beta 1.18
Public Float 31.70M P/E Ratio 20.26
% Short of Float - Dividend (Yield) 1.00 (0.00%)
Held by Insiders 66.79% Ex-Dividend Date Feb 9, 2022
Held by Institutions 4.10% IPO Date -

AARTIDRUGS Financial Summary

Mar 21 Mar 20 Mar 19
Revenue INR21.55B INR18.06B INR15.61B
Net Income INR2.80B INR1.41B INR897.51M
Total Assets INR17.66B INR15.77B INR14.63B
Total Cash INR88.13M INR67.71M INR46.44M
Total Debt INR3.51B INR3.89B INR5.07B
Dec 21 Sep 21 Jun 21
Revenue INR6.35B INR5.80B INR5.80B
EBITDA INR966.60M INR738.30M INR813.10M
Net Income INR582.87M INR425.90M INR488.10M
Total Assets INR INR18.91B INR
Total Cash INR INR65.50M INR
Total Debt INR INR4.70B INR

AARTIDRUGS Stock Price History

Aarti Drugs Annual Stock Price History

Year Open Close Change
2021 INR525.50 INR515.50 -1.90%
2021 INR710.00 INR525.50 -25.99%
2020 INR579.30 INR710.00 22.56%

Aarti Drugs Daily Stock Price History

Date Open High Low Close Change Volume
May 30, 2022 INR414.80 INR427.50 INR414.60 INR425.35 -0.39% 67.93K
Jun 10, 2022 INR425.00 INR430.15 INR423.50 INR427.00 1.34% 25.37K
Jun 7, 2022 INR426.05 INR429.00 INR415.15 INR421.35 7.36% 51.96K


What is today's stock price of Aarti Drugs (NSE:AARTIDRUGS)?

  • The current stock price of Aarti Drugs (NSE:AARTIDRUGS) is INR515.50.
  • Today AARTIDRUGS stock price opened at INR522.95 after previous close of INR519.80.
  • During the day, Aarti Drugs stock quote has varied from a low of INR508.80 to a high of INR525.00.

What is Aarti Drugs's 52-week change?

  • AARTIDRUGS 52-week high stock quote is INR840.19, which is 63.00% above the current share price.
  • The Aarti Drugs (NSE:AARTIDRUGS) 52-week low stock price is INR419.00, which is 18.70% below the current share price.
  • Aarti Drugs share price volatility (52-week beta) is 1.18.


How Much is Aarti drugs Worth?

Aarti drugs's worth today based on market capitalisation is INR40.69B

How much dividend does Aarti drugs Pay?

The current annualized dividend payout for AARTIDRUGS stock is INR1.00, the dividend yield is 0.22% and the payout ratio is 0.00%.
View More Details on Aarti drugs's "Dividend" Section

What is Aarti drugs’s Price to Earning (PE) ratio?

Aarti drugs has a Price to Earning (P/E) ratio of 20.26. AARTIDRUGS stock also has a Price to Sales (P/S) ratio of 1.77.

What is the Aarti drugs's ticker?

Aarti drugs trades on the NSE stock market in India under the ticker symbol "AARTIDRUGS". Aarti drugs’s stock symbol can also be displayed as "NSE:AARTIDRUGS".

Who are the owners of Aarti drugs?

Aarti drugs (NSE:AARTIDRUGS) is owned by 4.10% institutional shareholders and by 66.79% insiders. The rest is owned by the public.
Explore More Details on Aarti drugs's “Ownership” Section

Who are the key executives of Aarti drugs (AARTIDRUGS)?

Aarti drugs's key executive team includes the following managers:

  • Mr. Prakash Moreshwar Patil, Chairman, MD, CEO & Head of BR (1947)
  • Mr. Harshit Manila Savla, Joint MD & Exec. Director (1962)
  • Mr. Harit Pragji Shah, Whole-Time Director (1963)
  • Mr. Uday Moreshwar Patil, Whole-Time Director (1963)
  • Mr. Rashesh Chandrakant Gogri, MD & Exec. Director (1974)
  • Mr. Adhish Prakash Patil, CFO & Director (1983)
  • Mr. Dhanaji L. Kakade, VP of Technical (NA)
  • Mr. Rushikesh Deole, Company Sec. & Compliance Officer (NA)
  • Mr. Vishwa Harshit Savla, Director of Pinnacle of Life Sciences (NA)

What is Aarti drugs’s Sector & Industry Classification?

Aarti drugs (NSE:AARTIDRUGS) is classified under the "Healthcare" sector and under the "Drug Manufacturers-Specialty & Generic" industry.

How many employees work for Aarti drugs?

Currently the number of employees working for Aarti drugs is 1,620.

Where are Aarti drugs's Headquarters?

Aarti drugs (NSE:AARTIDRUGS) is headquartered in India.

What are Aarti drugs's Address and Phone Number?

Aarti drugs’s mailing address is Mahendra Industrial Estate, Mumbai, India, 400 022.
The company’s phone number is 91 22 2401 9025.

What is the official website for Aarti drugs?

Aarti drugs’s official website is http://www.aartidrugs.co.in